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Abstract: The effect of vigorous physical activity on mortality in the el-
derly is difficult to estimate using conventional approaches to causal infer-
ence that define this effect by comparing the mortality risks corresponding
to hypothetical scenarios in which all subjects in the target population en-
gage in a given level of vigorous physical activity. A causal effect defined
on the basis of such a static treatment intervention can only be identified
from observed data if all subjects in the target population have a posi-
tive probability of selecting each of the candidate treatment options, an
assumption that is highly unrealistic in this case since subjects with seri-
ous health problems will not be able to engage in higher levels of vigorous
physical activity. This problem can be addressed by focusing instead on
causal effects that are defined on the basis of realistic individualized treat-
ment rules and intention-to-treat rules that explicitly take into account the
set of treatment options that are available to each subject. We present a
data analysis to illustrate that estimators of static causal effects in fact
tend to overestimate the beneficial impact of high levels of vigorous physi-
cal activity while corresponding estimators based on realistic individualized
treatment rules and intention-to-treat rules can yield unbiased estimates.
We emphasize that the problems encountered in estimating static causal
effects are not restricted to the IPTW estimator, but are also observed with
the G-computation estimator, the DR-IPTW estimator, and the targeted
MLE. Our analyses based on realistic individualized treatment rules and
intention-to-treat rules suggest that high levels of vigorous physical activity
may confer reductions in mortality risk on the order of 15-30%, although
in most cases the evidence for such an effect does not quite reach the 0.05
level of significance.
AMS 2000 subject classifications: Primary 62P10, 62P10; secondary
62P10.
Keywords and phrases: Experimental Treatment Assignment assump-
tion, positivity assumption, dynamic treatment rules, physical activity.
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1. Introduction
A substantial body of epidemiologic research indicates that recent and current
physical activity in the elderly are associated with reductions in cardiovascular
morbidity and mortality and improvement in or prevention of metabolic abnor-
malities that place elderly people at risk for these outcomes [2; 5; 8; 21; 27].
Based on these findings, the CDC currently recommends that elderly people en-
gage in moderate-intensity physical activities such as bicycling on level terrain
for 30 minutes or more at least five times a week in order to maintain their
health [3].
While epidemiologic studies have produced compelling evidence for the health
benefits provided by such moderate-intensity physical activities, it remains a
largely open question to what extent more vigorous physical activities can offer
additional benefits to the elderly. One of the main reasons for why this question
has proven difficult to investigate lies in the difficulties encountered by conven-
tional statistical methods for causal inference in this context. These methods
would typically define the causal effect of vigorous physical activity on a health
outcome of interest by comparing the distribution of that outcome under the
hypothetical scenario in which all subjects in the target population exercise at
a given activity level to the corresponding distribution under the reference sce-
nario in which all subjects abstain from vigorous physical activity. In order to
estimate such treatment-specific counterfactual outcome distributions from ob-
servational data, however, one has to assume not only that the investigator has
recorded all relevant confounding factors, but also that all subjects in the target
population have a positive probability of selecting each of the treatment levels
under consideration. Intuitively, this latter positivity assumption, also referred
to as the assumption of experimental treatment assignment (ETA), makes sense
since we should not be able to estimate the counterfactual outcome distribution
corresponding to a given treatment level if there exists a subgroup of the target
population that in reality is never observed at that treatment level.
In the context of studying the benefits of vigorous physical activity in the
elderly, this assumption appears highly unrealistic for two reasons. First, serious
health problems would prevent a considerable proportion of subjects from ever
participating in the highest level of vigorous physical activity. Since we could not
devise an intervention under which such subjects would exercise at the highest
level, the corresponding counterfactual outcomes, as first pointed out by Robins
[13; 14], are not even well defined, making it in fact meaningless to talk about
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an outcome distribution we would observe if all subjects were assigned to the
highest activity level [18]. Second, while it may be more reasonable to assume
that all subjects could at least hypothetically participate in intermediate activity
levels, we might still expect that there is a fair number of subjects in our target
population that due to poor health would in reality only be observed at the very
lowest activity levels. In the absence of strong additional modeling assumptions,
such a violation of the ETA assumption would likley cause a conventional causal
analysis to overestimate the beneficial impact of higher levels of vigorous exercise
since any estimate of the corresponding counterfactual distribution would be
based on a group of subjects that is healthier than the population as a whole
[13; 14].
These two problems can be addressed by defining the causal effect of interest
on the basis of interventions that, in contrast to the static interventions de-
scribed above, explicitly take into account the set of treatment options available
to each subject [13; 14]. In the present case, we might consider hypothetical
scenarios in which subjects are assigned to a particular vigorous activity level
unless they rate their own health as poor, in which case they will be assigned
to the lowest activity level. The causal effect of vigorous physical activity could
then be defined by comparing the outcome distribution we would observe for
different target levels to the corresponding distribution we would observe under
no vigorous physical activity. Both Inverse-Probability-of-Treatment-Weighted
(IPTW) [15; 19] and double robust [20; 24] estimators for mean counterfac-
tual outcomes corresponding to such individualized treatment rules have been
proposed.
Recently such estimators have also been been proposed for two kinds of real-
istic interventions that, unlike in the example above, are not specified a priori by
the investigator, but are instead defined implicitly on the basis of the observed
data [12; 28]. These interventions make use of a subject’s estimated conditional
probability of selecting a particular treatment option, given baseline characteris-
tic, to decide if that treatment option is realistic. Specifically, treatment options
are considered unrealistic if this estimated probability falls below a user-supplied
minimum level such as 0.05. The first intervention is based on realistic individ-
ualized treatment rules that assign a treatment level that is as close as possible
to a specified target level while still being a realistic option for that subject.
In the context of physical activity, for instance, we might consider rules that
assign subjects to the highest vigorous activity level not exceeding a specified
target level that they are still realistically capable of. The second intervention
is based on intention-to-treat rules that, like realistic individualized treatment
rules, attempt to assign subjects to a specified target level, but allow subjects
for whom this target level is not realistic to follow their self-selected treatment
level rather than assigning them to the next highest realistic level. Causal effect
estimates based on such rules thus aim to produce the results of an intention-
to-treat analysis of a randomized trial in which a proportion of subjects fail to
comply with treatment assignment and instead select their own treatment level.
In this article, we present a data analysis examining the potential benefits of
vigorous-intensity physical activity that compares the results obtained through
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a conventional analysis to those based on realistic indivualized treatment and
intention-to-treat rules. Our analysis illustrates that a conventional analysis
based on static treatment rules yields severely biased results that dramatically
overestimate the true effect of higher levels of vigorous physical activity. At
the same time, we show that causal effects based on realistic individualized
treatment rules and intention-to-treat rules can be estimated without bias. The
remainder of the article is organized as follows. After describing our data source,
we briefly review the counterfactual framework for causal inference and describe
the various estimators that have been proposed for estimating causal effects. We
then present the details of our data analysis and close with a brief discussion of
our results.
2. Data source
Tager et al. [26] followed a group of people aged 55 years and older living in
and around Sonoma, CA, over a time period of about ten years as part of a
community-based longitudinal study of physical activity and fitness (Study of
Physical Performance and Age Related Changes in Sonomans - SPPARCS). Our
goal in analyzing the data that were collected as part of this study is to examine
the effect of vigorous LTPA as recorded at the baseline interview on subsequent
five-year all-cause mortality.
Our measure of vigorous LTPA is defined based on a questionnaire in which
participants were asked how many hours during the past seven days they had
participated in twelve common vigorous physical activities such as jogging,
swimming, bicycling on hills, or racquetball. Activities were assigned standard
intensity values in metabolic equivalents (METs) [1]; one MET approximately
equals the oxygen consumption required for sitting quietly. A continuous sum-
mary score was obtained by multiplying these intensity values by the number
of hours engaged in the various activities and summing up over all activities
considered here. The treatment variable A was then defined as a categorical
version of this summary LTPA score:
A =


0 if LTPA = 0 METs
1 if 0 METs < LTPA ≤ 10 METs
2 if 10 METs < LTPA ≤ 20 METs
3 if 20 METs < LTPA ≤ 40 METs
4 if 40 METs < LTPA ≤ 60 METs
5 if 60 METs < LTPA
(1)
To compare, the current CDC recommendation for engaging in moderate-intensity
physical activity for 30 minutes at least five times a week corresponds to an en-
ergy expenditure of 22.5 METs.
Apart from sex and age, the primary confounding factor of the relationship
between LTPA and all-cause mortality is likely to be given by a subject’s under-
lying level of general health. Healthier subjects will not only tend to experience
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lower mortality risks, but are also more likely to engage in higher levels of vig-
orous physical activity. To control for this source of confounding, our analysis
adjusts for a number of covariates that are intended to capture a subject’s un-
derlying level of health. Participants were asked, for instance, to rate their health
as excellent, good, fair, or poor. Self-reported physical functioning was defined
from a series of questions that assessed the degree of difficulty a participant
experienced in various activities of daily living [9; 22]. On the basis of this ques-
tionnaire, we classified a participant’s level of physical functioning as excellent,
moderately impaired, or severely impaired. In addition, participants were asked
about the previous occurrence of cardiac events such as myocardial infarctions,
the presence of a number of chronic health conditions, their smoking status, as
well as a possible decline in physical activity compared to 5 or 10 years earlier.
Table 1 summarizes the definition of the covariates we adjust for as potential
confounding factors.
Table 1
Definition of indicator variables that are considered as potential confounders.
Variable Definition
FEMALE Female
AGE.1 ≤ 60 years old
AGE.2 60-70 years old
AGE.4 80-90 years old
AGE.5 90-100 years old
HTL.EX Excellent self-rated health
HLT.FAIR Fair self-rated health
HLT.POOR Poor self-rated health
NRB.FAIR Moderately impaired physical functioning (0.5 ≤ NRB score ¡ 1.0)
NRB.POOR Severely impaired physical functioning (NRB score ¡ 0.5)
CARD Previous occurrence of any of the following cardiac events: Angina,
myocardial infarction, congestive heart failure, coronary by-pass
surgery, and coronary angioplasty
CHRON Presence of any of the following chronic health conditions: stroke,
cancer, liver disease, kidney disease, Parkinson’s disease, and
diabetes mellitus
SMK.CURR Current smoker
SMK.EX Former smoker
DECLINE Activity decline compared to 5 or 10 years earlier
Of the 2092 participants enrolled in the SPPARCS study, 15 did not answer
all the questions needed to define their level of vigorous physical activity; an
additional 26 were missing information about at a least one of the confound-
ing factors described above. Our analysis is based on the remaining 2051 par-
ticipants. We note that the outcome of interest, five-year survival status, was
available for all study participants so that we do not have to adjust for right
censoring.
Bembom and van der Laan/Realistic individualized treatment rules 579
3. Methods
The observed data are given by n i.i.d. copies of O = (W,A, Y ), where W
denotes the collection of adjustment variables, A gives the categorical physical
activity level, and Y is an indicator for death in the five years following the
baseline interview. Within the counterfactual framework for causal inference,
as first introduced by Neyman [11] and further developed by Rubin [23] and
Robins [13; 14], this observed data structure O is viewed as a censored version
of a hypothetical full data structure X = (Ya : a ∈ A) that contains the outcome
Ya we would have observed on this subject had she been assigned to treatment
level a for all a in the collection A = {0, 1, . . . , 5} of possible treatment levels.
The causal effect of vigorous physical activity on all-cause mortality could now
be defined by comparing the mortality risk E[Ya] we would observe if all subjects
in the target population exercised at a given level a > 0 to the corresponding
mortality risk E[Y0] we would observe if all subjects abstained from vigorous
physical activity. As discussed above, this definition of a causal effect would
require, however, that the counterfactual outcomes Ya are well defined for all
subjects.
A mean counterfactual outcome E[Ya] can only be estimated from the ob-
served data if the investigator has recorded all relevant confounding factors and
if all subjects in the target population have positive probability of selecting each
of the treatment levels. This latter assumption of experimental treatment as-
signment can be formalized by requiring that for all candidate static treatment
interventions a = 0, 1, . . . , 5, we have with probability 1.0 that
g(a |W ) ≡ P (A = a |W ) > 0. (2)
In fact, it has been shown that estimation of mean counterfactual outcomes
becomes problematic even if there exist values of a and W for which the treat-
ment assignment probabilities g(a | W ) are not identically equal to zero, but
very close to zero [10]. To avoid problems due to such a practical violation of
the ETA assumption, we may hence require in practice that, for a = 0, 1, . . . , 5,
we have g(a |W ) > α with probability 1.0, with α = 0.05, for instance.
Estimators of causal effects defined on the basis of the realistic individualized
treatment rules do not rely on the ETA assumption. Given a target treatment
level a and a subject’s baseline covariates W , such rules assign the highest
treatment level not exceeding a that the subject is still realistically capable of.
Specifically, let
D(W ) = {a ∈ A : g(a |W ) ≥ α} (3)
denote the set of treatment options that, given baseline covariates W , are real-
istic for a particular subject in the sense that she would select any one of those
treatment options with a probability of at least α. A realistic individualized
treatment rule can then be defined as
d(a,W ) = max{a∗ ∈ D(W ) : a∗ ≤ a}. (4)
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As with static treatment regimens, we use the notation Yd(a,W ) to denote the
outcome we would have observed on the subject had she followed the individu-
alized rule d(a,W ), i.e. Yd(a,W ) ≡ Ya˜ where a˜ = d(a,W ). A realistic causal effect
of vigorous physical activity on all-cause mortality can now be defined by com-
paring the mortality risk E[Yd(a,W )] we would observe if all subjects in the target
population followed a given rule d(a,W ), a > 0, to the corresponding mortality
risk E[Yd(0,W )] = E[Y0] we would observe if all subjects abstained from vigorous
physical activity. By the definition of d(a,W ), we have, for a = 0, 1, . . . , 5, that
g(d(a,W ) | W ) > α with probability 1.0, demonstrating that the equivalent
of assumption (2) is trivially satisfied in estimating the corresponding causal
effects.
Under an intention-to-treat rule d(a,A,W ), subjects are assigned to a speci-
fied target treatment level a if that treatment level represents a realistic option
for them, but are allowed to follow their self-selected treatment A otherwise:
d(a,A,W ) = I(a ∈ D(W ))a+ I(a /∈ D(W ))A. (5)
An intention-to-treat causal effect of vigorous physical activity on all-cause
mortality can now be defined by comparing the counterfactual mortality risks
E[Yd(a,A,W )], a > 0, and E[Yd(0,A,W )] = E[Y0]. Note that we have
E[Yd(a,A,W )] = E
[
YaI(a ∈ D(W ))
]
+ E
[
Y I(a /∈ D(W ))
]
. (6)
The second quantity is trivially identified by the observed data, and a ∈ D(W )
guarantees that g(a | W ) > α with probability 1.0, ensuring identifiability of
the second quantity, so that the equivalent of assumption (2) is guaranteed to
hold in the estimation of intention-to-treat causal effects. We note that the true
treatment mechanism g and therefore also the set D(W ) of realistic treatment
options will generally be unknown. In practice, it will therefore usually be nec-
essary to substitute a given estimate g∗ of the treatment mechanism g in the
definition of D(W ).
Several different classes of estimators have been proposed for estimating mean
counterfactual outcomes corresponding to static treatment rules:G-computation
estimators [13], Inverse-Probability-of-Treatment-Weighted (IPTW) estimators
[16], double robust IPTW (DR-IPTW) estimators [29], regression-like DR esti-
mators [16] that were later recognized to be an example of the general class of
targeted maximum-likelihood estimators [30], and the d− d∗ structural-nested-
mean-model (SNMM) estimators [17]; all of these estimators have natural ana-
logues in the context of realistic individualized treatment rules and intention-
to-treat rules. While it is well known that the IPTW estimator can suffer from
considerable bias if the ETA assumption is violated, the remaining four estima-
tors are in fact also severely compromised in such situations in that they now
have to rely fully on model assumptions that cannot be tested from the data
[10]. Since this latter phenomenon is rarely discussed in the literature, we will
provide a practical illustration by comparing the estimates obtained by the first
four of these estimators for the three different causal effects defined above. We
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next review the definition and implementation of the four estimators of interest
in order to be able to discuss their behavior in more detail.
We begin with estimators of the mean counterfactual outcome ψ = E[Yd(a,W )]
for a given realistic individualized treatment rule d(a,W ). Note that the mean
counterfactual outcome E[Ya] for a given static treatment rule corresponds to
the special case of setting α = 0 in the definition of D(W ). The G-computation
estimator of ψ is based on the observation that under the assumption of no
unmeasured confounders, this parameter is identified by the observed data as
ψ = E[Yd(a,W )] = EW
[
E[Y | A = d(a,W ),W ]
]
. (7)
This immediately implies a substitution estimator based on estimates of the
marginal distribution ofW , P (W ), and the conditional distribution of Y given A
andW , P (Y | A,W ). The first distribution can be estimated non-parametrically
by the empirical distribution ofW in our sample, but estimation of P (Y | A,W )
will generally require specification of a parametric model. In the case of a binary
outcome Y , an estimate Qn of the regression Q(A,W ) = E[Y | A,W ] based on
an appropriate logistic regression model completely defines an estimate of the
conditional distribution P (Y | A,W ). The corresponding substitution estimator
for ψ is then given by
ψG−compn =
1
n
n∑
i=1
Qn(d(a,Wi),Wi). (8)
This estimator gives a consistent estimate of ψ if the model for Q(A,W ) is
correctly specified.
The IPTW and DR-IPTW estimators are based on a general estimating func-
tion methodology that is based on the following three steps [29]. First, estimat-
ing functions for ψ are obtained assuming that we have access to the full data
structure X . These estimating functions are then mapped into functions of the
observed data structure by applying an IPTW mapping. Lastly, a class of more
robust and efficient estimating functions is obtained by subtracting from these
IPTW estimating functions their projection onto the tangent space for the treat-
ment mechanism in the model that only makes the assumption of no unmeasured
confounders. In a non-parametric model, the only unbiased full-data estimating
function for ψ is given by
DFull(X | ψ) = Yd(a,W ) − ψ. (9)
A corresponding IPTW estimating function is given by
DIPTW (O | g, ψ) =
I(A = d(a,W ))
g(A |W )
Y − ψ. (10)
The IPTW estimator ψIPTWn is defined as the solution of the estimating equa-
tion
0 =
1
n
n∑
i=1
DIPTW (Oi | gn, ψ), (11)
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where gn is an estimate of g that may, for example, be obtained as the maximum-
likelihood estimate of g in an appropriately specified parametric model. Specif-
ically, this estimator is given by
ψIPTWn =
1
n
n∑
i=1
I(Ai = d(a,Wi))
gn(Ai |Wi)
Yi. (12)
It gives a consistent estimate of ψ if the model for the treatment mechanism g
is correctly specified.
The projection of DIPTW onto the nuisance tangent space TNUC correspond-
ing to the treatment mechanism under the assumption of no unmeasured con-
founders can be computed as
Π[DIPTW | TNUC ] = E[D
IPTW | A,W ]− E[DIPTW | W ]
=
I(A = d(a,W ))
g(A |W )
Q(A,W )−Q(d(a,W ),W )
so that the DR-IPTW estimating function is given by
DDR(O | g,Q, ψ) =
I(A = d(a,W ))
g(A | W )
[
Y −Q(A,W )
]
+Q(d(a,W ),W )−ψ. (13)
The corresponding DR-IPTW estimator ψDRn is defined as the solution of the
estimating equation
0 =
1
n
n∑
i=1
DDR(Oi | gn, Qn, ψ). (14)
Specifically,
ψDRn =
1
n
n∑
i=1
I(Ai = d(a,Wi))
gn(Ai |Wi)
[
Yi −Qn(Ai,Wi)
]
+Qn(d(a,Wi),Wi). (15)
This estimator gives a consistent estimate of ψ if the model for either g or Q is
correctly specified. It is also locally efficient in the sense that correct specification
of both models yields an efficient estimator.
Like the G-computation estimator, the targeted MLE of ψ is a substitution
estimator based on estimates of the components P (W ) and P (Y | A,W ) of the
observed data density. In order to avoid relying on an a priori specified paramet-
ric model for the latter component, we may often want to employ a data-adaptive
model selection approach such as the Deletion/Substituion/Addition algorithm
[25] or Least Angle Regression [4] for the purposes of estimating this conditional
density. This is somewhat problematic, however, since such algorithms will se-
lect an appropriate model based on a criterion that is aimed at estimating the
nuisance parameter P (Y | A,W ) efficiently, which in general does not lead to an
efficient estimator of the parameter of interest ψ. The targeted MLE therefore
first updates the initial estimate of the observed-data density that would be
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used by the G-computation estimator in a way that targets estimation of this
density at the parameter of interest and makes the corresponding substitution
estimator double robust and locally efficient. Specifically, this is achieved by for-
mulating a parametric model indexed by a Euclidean parameter ǫ through the
initial estimate of the observed-data density at ǫ = 0 whose scores include the
components of the efficient influence curve of ψ at the initial density estimate,
obtaining a maximum-likelihood estimate of ǫ in this model, and updating the
original density estimate accordingly.
Since this targeted maximum-likelihood approach was only recently devel-
oped, we will illustrate it here in the context of estimating the parameter of
interest ψ. For this purpose, let P 0n be an initial estimator of the observed-data
density that estimates the marginal distribution ofW by the empirical distribu-
tion ofW , the treatment mechanism g by an estimate g(P 0n), and the conditional
distribution of Y given A andW by an initial fit Q(P 0n) that can be represented
in the form of the logistic function
Q(P 0n)(A,W ) =
1
1 + exp(−m0n(A,W ))
. (16)
We then need to formulate a parametric fluctuation through this initial density
estimate whose scores at the initial estimate include the components of the effi-
cient influence curve for ψ. This efficient influence curve, given by the influence
curve D(P ) of the DR-IPTW estimator
D(P ) =
I(A = d(a,W ))
g(A |W )
[
Y −Q(A,W )
]
+Q(d(a,W ),W )− ψ, (17)
can be decomposed as
D(P ) = D(P )− E[D(P ) | A,W ] +
E[D(P ) | A,W ]− E[D(P ) |W ] +
E[D(P ) |W ]− E[D(P )], (18)
corresponding to scores for P (Y | A,W ), P (A | W ), and P (W ), respectively.
Specifically, we have that
D1(P ) = D(P )− E[D(P ) | A,W ]
=
I(A = d(a,W ))
g(A |W )
[
Y −Q(A,W )
]
(19)
D2(P ) = E[D(P ) | A,W ]− E[D(P ) |W ]
= 0 (20)
D3(P ) = E[D(P ) |W ]− E[D(P )]
= Q(d(a,W ),W )− ψa. (21)
Since the empirical distribution of W is a non-parametric maximum-likelihood
estimator of P (W ), it in particular equals the MLE of P (W ) in any parametric
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fluctuation through this initial estimate so that we do not need to concern
ourselves with updating this component of the observed-data density. Since
the parameter of interest is orthogonal to the treatment mechanism g so that
D2(P ) = 0, we also do not need to obtain an update of an initial estimate of
g. As a submodel through P 0n(Y | A,W ), we will consider a logistic regression
model that is identical to the initial fit Q(P 0n) except for an added covariate
h(P 0n)(A,W ):
Q(P 0n)(ǫ)(A,W ) =
1
1 + exp(−m0n(A,W )− ǫh(P
0
n)(A,W ))
(22)
The covariate h(P 0n)(A,W ) needs to be chosen such that the score of this sub-
model at ǫ = 0 is equal to D1(P
0
n), the component of the efficient influence curve
corresponding to P (Y | A,W ) at the initial density estimate. The score of the
selected submodel at ǫ = 0 is given by
S(0) = h(P 0n)(A,W )
(
Y −Q(P 0n)(A,W )
)
. (23)
Solving for h such that
S(0) = D1(P
0
n)
=
I(A = d(a,W ))
g(P 0n)(A |W )
[
Y −Q(P 0n)(A,W )
]
(24)
yields the solution
h(P 0n)(A,W ) =
I(A = d(a,W ))
g(P 0n)(A |W )
. (25)
Let ǫn denote the MLE of ǫ in Q(P
0
n)(ǫ), which can be obtained by simply
regressing Y on h(P 0n)(A,W ) according to a logistic regression model with offset
equal to m0n(A,W ). The targeted MLE of ψ is then given by the substitution
estimator based on the updated estimate
Q1n(A,W ) =
1
1 + exp(−m0n(A,W )− ǫnh(P
0
n)(A,W ))
(26)
of the regression Q(A,W ). Specifically, we have that
ψtMLEn =
1
n
n∑
i=1
Q1n(d(a,Wi),Wi). (27)
To summarize, implementing this estimator thus requires initial estimates of the
regression Q and the treatment mechanism g as they would also be used by the
three estimators described above, updating the estimate for Q in a simple uni-
variate logistic regression, and then computing the corresponding substitution
estimator of ψ. The resulting targeted MLE solves the double robust estimating
equation based on Q1n(A,W ) and gn, i.e.
1
n
n∑
i=1
I(Ai = d(a,Wi))
g(P 0n)(Ai |Wi)
[
Yi −Q
1
n(Ai,Wi)
]
+Q1n(d(a,Wi),Wi)− ψ
tMLE
n = 0,
(28)
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so that it is in fact equivalent to the DR-IPTW estimator given in (15) with
Q1n(A,W ) substituted forQn(A,W ). Like the DR-IPTW estimator, the targeted
MLE is therefore consistent if at least one of the two nuisance parameters g
and Q is estimated consistently. Similarly, the estimator is locally efficient in
the sense that it is efficient if both of these nuisance parameters are estimated
consistently.
As mentioned previously, estimation of the mean counterfactual outcome
E[Ya] corresponding to a static treatment intervention represents a special case
of the realistic individualized treatment rules considered here. G-computation,
IPTW, and DR-IPTW estimators of the mean counterfactual outcome φ ≡
E[Yd(a,A,W )] corresponding to an intention-to-treat rule are straightforward to
derive and are presented elsewhere [28]. In order to obtain a targeted MLE of φ,
we can use that by (6) the efficient influence curve of φ in a non-parametric model
can be written as the sum of the efficient influence curve of a non-parametric
estimator of φ1 = E[Y I(a /∈ D)] and the efficient influence curve of a non-
parametric estimator of φ2 = E[YaI(a ∈ D)]. These are given by
D1(P ) = I(a /∈ D)Y − φ1 (29)
and
D2(P ) = I(a ∈ D)
{
I(A = a)
g(A |W )
[
Y −Q(A,W )
]
+Q(a,W )
}
− φ2, (30)
respectively, yielding
D(P ) = I(a /∈ D)Y + I(a ∈ D)
{
I(A = a)
g(A |W )
[
Y −Q(A,W )
]
+Q(a,W )
}
− φ
(31)
as the efficient influence curve for φ. The component of this influence curve
corresponding to the score for P (Y | A,W ) is given by
D(P )−E[D(P ) | A,W ]
=I(a /∈ D)
[
Y −Q(A,W )
]
+ I(a ∈ D)
{
I(A = a)
g(A |W )
[
Y −Q(A,W )
]}
=
{
I(a /∈ D) + I(a ∈ D)
I(A = a)
g(A | W )
}[
Y −Q(A,W )
]
. (32)
The covariate h(P 0n)(A,W ) needed for the univariate regression to update the
initial fit for Q is thus given by
h(P 0n)(A,W ) = I(a /∈ D) + I(a ∈ D)
I(A = a)
g(P 0n)(A |W )
. (33)
The problems arising if the ETA assumption is violated are most clearly seen
in the case of the IPTW estimator. By downweighting observations that were
likely to have received their observed treatment and upweighting those that
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were instead unlikely to have received their observed treatment, this estimator
essentially works by creating a new sample in which treatment assignment is
independent of the baseline covariates. This approach breaks down if a subgroup
of the target population never selects some of candidate treatment levels. If
older, less healthy subjects, for example, are never observed to participate in
high levels of vigorous physical activity, none of the subjects in the corresponding
re-weighted sample will be older and less healthy, leading to an underestimate
of the corresponding counterfactual mortality risk under high levels of vigorous
physical activity.
In the same situation, the G-computation estimator has to rely entirely on
model assumptions that cannot be tested from the observed data. Since older,
less healthy subjects are never observed at higher levels of vigorous physical
activity, their conditional mean outcome E[Y | A,W ] for these exercise levels is
undefined. A corresponding estimate can never be obtained from the observed
data unless one is willing to extrapolate from the conditional mean outcomes
estimated for other values of A and W . To illustrate this point, consider the
simplified example in which A is a binary indicator for a high level of vigorous
physical activity and W is an indicator for poor health. Then none of the sub-
jects in our target population might fall in the group with W = 1 and A = 1
so that E[Y | A = 1,W = 1] is undefined. In order to still obtain an estimate
of this quantity, we would be forced to assume an additive model for Q ac-
cording to which Q(A,W ) = β0 + β1A+ β2W . Since the non-parametric model
Q(A,W ) = β0 + β1A+ β2W + β3A×W is not identifiable, this assumption of
no interaction between A and W cannot be tested from the observed data.
Like the G-computation estimator, the DR-IPTW estimator and the targeted
MLE rely entirely on extrapolation throughQ if the ETA assumption is violated.
To complicate matters, however, they also require that the estimate of g is based
on a model for the treatment mechanism that satisfies the ETA assumption, i.e.
the model for g must in fact be mis-specified [29]. In summary, all four estimators
of causal effects are thus severely compromised if the ETA assumption does not
hold, illustrating that the solution in such cases does not lie in turning to the
G-computation or DR-IPTW estimators for which the resulting problems are
not as immediately apparent as for the IPTW estimator, but in focusing on
realistically defined causal effects that are guaranteed to be identified from the
observed data.
4. Results
The treatment mechanism was estimated by a multinomial regression model
that included main-effect terms for all indicator variables defined in Table 1.
The regression E[Y | A,W ] was similarly estimated by a logistic regression
model that included these same main-effect terms as well as indicator variables
for the treatment categories 1 through 5. We evaluated the goodness-of-fit of
this latter model using the Hosmer-Le Cessie test [7]. This test yielded a p-
value of 0.10, providing little evidence against the assumption that this model
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adequately describes the data. To evaluate the fit of our treatment model, we
followed the advise of Hosmer and Lemeshow [6] and treated this model as a
set of independent binary logistic regression models of each treatment category
against the remaining categories. Applying the Hosmer-Le Cessie test to each of
these binary logistic regression models, we obtained p-values of 0.51, 0.54, 0.33,
0.27, 0.78, and 0.94, suggesting that the treatment model fits the data quite
well.
Tables 2 and 3 summarize the fits we obtained for g and Q, respectively. The
treatment fit reveals that older, less healthy subjects do not have available the
full set of treatment options: No subjects in the oldest age group (90-100 years)
are observed at the treatment levels A = 3 and A = 5. Likewise, no subjects with
poor self-rated health are observed at the treatment levels A = 4 and A = 5. In
addition, subjects with severely impaired physical functioning are very unlikely
to follow treatments A = 4 and A = 5. The fit we obtained for Q indicates that
these three groups of subjects are at considerably increased risks of mortality,
suggesting that estimates of the counterfactual mortality risks for the higher
three treatment categories will be biased low. Since the DR-IPTW estimator
and the targeted MLE both require an estimate of the treatment mechanism
that satisfies the ETA assumption, fitted treatment assignment probabilities
below 0.05 were set to 0.05.
Table 2
Treatment model fit. The entries in the first column give the factor by which the relative risk
of falling in category A=1 rather than A=0 changes when the covariate under consideration
is changed from 0 to 1. Entries in the remaining columns are interpreted accordingly.
A=1 A=2 A=3 A=4 A=5
AGE.1 1.16 1.57 1.37 1.32 1.44
AGE.2 1.37 1.57 1.47 1.32 1.37
AGE.4 0.74 0.94 0.83 0.83 1.02
AGE.5 0.24 1.03 0.00 1.04 0.00
HLT.EX 1.09 1.10 1.46 1.29 1.67
HLT.FAIR 0.56 0.58 0.47 0.39 0.45
HLT.POOR 0.50 0.43 0.33 0.00 0.00
NRB.POOR 0.55 0.40 0.29 0.07 0.17
NRB.FAIR 0.78 0.82 0.70 0.99 0.53
SMOKE.CURR 0.65 0.43 0.32 0.61 0.33
SMOKE.EX 1.00 1.23 1.09 1.25 1.20
CARD 0.90 1.29 1.18 0.89 1.46
CHRONIC 1.19 1.14 1.13 1.11 0.93
FEMALE 0.94 0.86 0.82 0.89 0.55
DECLINE 0.67 0.39 0.52 0.37 0.33
Tables 4 and 5 summarize the realistic indvidualized treatment rule and the
intention-to-treat rule. Both Tables show that only about 50% of all subjects
are estimated to be capable of engaging in the highest level of vigorous physical
activity. Likewise, only about 75% of all subjects are estimated to be capable of
the second highest level. These observations further suggest that counterfactual
outcomes for higher activity levels are not well defined for all subjects, or at least
that a considerable porportion of subjects in the target population are rarely
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Table 3
Fit for Q. Estimated odds ratios for mortality along with 95% confidence intervals and
p-values.
OR 95% CI p-value
AGE.1 0.12 (0.05, 0.31) < 0.0001
AGE.2 0.43 (0.29, 0.64) < 0.0001
AGE.4 3.41 (2.34, 4.96) < 0.0001
AGE.5 5.74 (2.07, 15.91) < 0.0001
HLT.EX 0.76 (0.50, 1.16) 0.2039
HLT.FAIR 2.01 (1.39, 2.93) < 0.0001
HLT.POOR 2.84 (1.51, 5.34) 0.0012
NRB.POOR 1.94 (1.21, 3.13) 0.0063
NRB.FAIR 0.89 (0.61, 1.29) 0.5279
SMOKE.CURR 3.73 (2.22, 6.29) < 0.0001
SMOKE.EX 1.38 (0.99, 1.94) 0.0584
CARD 1.60 (1.13, 2.26) 0.0080
CHRONIC 1.44 (1.06, 1.95) 0.0204
FEMALE 0.52 (0.37, 0.72) < 0.0001
DECLINE 1.46 (1.05, 2.05) 0.0266
A=1 0.86 (0.55, 1.34) 0.5072
A=2 0.81 (0.51, 1.29) 0.3849
A=3 0.78 (0.47, 1.29) 0.3360
A=4 0.45 (0.18, 1.09) 0.0770
A=5 0.80 (0.37, 1.76) 0.5866
observed at these activity levels. In comparing Tables 4 and 5, we note that
the intention-to-treat causal effects of high levels of vigorous physical activity
are likely to be smaller than the corresponding realistic causal effects. Under
the intention-to-treat rule d(5, A,W ), close to 25% of all subjects are assigned
to the lowest treatment level A = 0 while the corresponding realistic individ-
ualized treatment rule d(5,W ) assigns no subjects to A = 0. In general, the
realistic individualized treatment rule results in treatment assignments closer to
the specified target level than those obtained from the intention-to-treat rule.
In addition, the latter rule produces a few cases in which subjects are assigned
to treatment levels that exceed the given target level. For the sake of estimating
the causal effect of vigorous physical activity, these observations would seem
to make the realistic individualized treatment rule a somewhat more appealing
option than the intention-to-treat rule.
Table 4
The realistic individualized treatment rule. A given row shows the treatment levels
a˜ ≡ d(a,W ) that subjects were actually assigned to when the target level was set at a.
a˜ = 0 a˜ = 1 a˜ = 2 a˜ = 3 a˜ = 4 a˜ = 5
a = 0 2051 0 0 0 0 0
a = 1 11 2040 0 0 0 0
a = 2 0 41 2010 0 0 0
a = 3 0 41 97 1913 0 0
a = 4 0 41 91 441 1478 0
a = 5 0 41 91 381 454 1084
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Table 5
The intention-to-treat treatment rule. A given row shows the treatment levels a˜ ≡ d(a, A,W )
that subjects were actually assigned to when the target level was set at a.
a˜ = 0 a˜ = 1 a˜ = 2 a˜ = 3 a˜ = 4 a˜ = 5
a = 0 2051 0 0 0 0 0
a = 1 11 2040 0 0 0 0
a = 2 35 3 2011 1 1 0
a = 3 108 16 7 1918 2 0
a = 4 338 88 66 56 1491 12
a = 5 492 161 134 110 45 1109
As argued above, the lack of non-parametric identifiability of causal param-
eters under a violation of the ETA assumption is most easily seen in the case of
the IPTW estimator which is likely to suffer from considerable bias. Wang et al.
[31] propose the following simulation-based approach for obtaining an estimate
of this bias: Given estimates of P (W ), g, and Q, we can simulate realizations of
the observed data structure. For this estimated data-generating distribution, the
true parameter values for the parameters of interest can be computed through
G-computation. At the same time, we can obtain a sampling distribution of
IPTW estimates by applying the IPTW estimator to a large number of sim-
ulated realizations of the observed data structure. Since the assumption of no
unmeasured confounders is trivially satisfied in this simulation study, any dis-
crepancy between the mean of these estimates and the true parameter value
must reflect a violation of the ETA assumption.
Table 6 summarizes the estimated bias of the IPTW estimator of the coun-
terfactual mortality risk for each of the three different kinds of causal effects.
The Table shows that the IPTW estimator dramatically underestimates the
counterfactual mortality risk for static treatment interventions at the highest
two activity levels, with considerable problems even for the third highest level
of activity. We note that the estimated bias for the highest activity level should
be treated with care since the corresponding static parameter is not even well
defined. The remainder of the results is in agreement with our earlier arguments
according to which a lack of older and less healthy subjects among the higher
activity levels should lead to an underestimate of the corresponding mortality
risks. In contrast, Table 6 shows only a negligible bias for estimating such risks
on the basis of realistic individualized treatment rules and intention-to-treat
rules. We stress that this diagnostic simulation should be interpreted to give
not only an estimate of the bias seen in the IPTW estimator, but, more gener-
ally, a sense of the extent to which an ETA violation makes the causal param-
eters of interest non-parametrically non-identifiable or even ill defined. In the
present case, for instance, we would therefore also want to treat any estimates
of static causal effects offered by the G-computation, DR-IPTW, and targeted
maximum-likelihood estimators as unreliable and potentially misleading.
Given the counterfactual mortality risk estimators described in section 3,
estimators of the relative risk (relative to A = 0) are straightforward to obtain
for the G-computation, IPTW, and DR-IPTW estimators by simply dividing the
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Table 6
Estimated ETA bias for the IPTW estimator of the counterfactual mortality risk as a
percentage of the true parameter value.
Static Realistic ITT
A=0 -0.23% -0.23% -0.23%
A=1 -2.63% 0.05% -0.03%
A=2 -4.94% 0.04% 0.13%
A=3 -14.45% 0.22% 0.20%
A=4 -48.75% 1.16% 1.05%
A=5 -50.54% -0.18% 0.11%
corresponding two mortality risk estimators. Since the targeted MLE is always
aimed at a particular parameter of interest, this simple approach does not work
for obtaining a targeted MLE of the relative risk of mortality. Section A in the
appendix shows that this task is still fairly straightforward, however, given the
work we have already done in section 3. Table 7 summarizes the relative risk
estimates for the three different kinds of causal effects obtained by the four
different estimators.
In the analysis based on static treatment interventions, the IPTW estimator
appears to provide strong evidence for a protective effect of vigorous physical
activity at the highest two levels, with an estimated 4-fold reduction in risk for
the second-highest level. The realistic and intention-to-treat analysis, however,
provide much weaker evidence for such a protective effect. As expected, the
intention-to-treat causal effect estimates tend to be closer to the null value than
the corresponding realistic estimates. Given the results of the simulation study
summarized in Table 6, we are led to conclude that the IPTW estimates based
on static treatment interventions dramatically overstate the beneficial impact
of high levels of vigorous physical activity.
The remaining three estimators likewise tend to estimate stronger reduc-
tions in risk in the static analysis than in the realistic and intention-to-treat
analyses, with both the DR-IPTW estimator and the targeted MLE indicat-
ing a significant protective effect for A = 4 in the static analysis that becomes
non-significant in the realistic and intention-to-treat analyses. Interestingly, the
G-computation estimator also yields a smaller estimated reduction in risk for
A = 4 in the latter two analyses than in the former one, but tighter confi-
dence intervals for the realistic and intention-to-treat analyses actually make
the corresponding causal effect estimates significant while this is not the case in
the static analysis. We speculate that the greater sampling variability observed
in the static analysis is likely a result of the extrapolation that is required to
estimate the expected mortality outcome for a large number of subjects that
are never observed at the highest two treatment levels. For all four estimators,
the static analysis suggest a markedly greater mortality risk for A = 5 than
for A = 4, a finding that would be quite hard to interpret. The remaining two
analyses, in contrast, provide much more compatible estimates for these two
activity levels. These observations lend credence to the idea that the static ef-
fect estimates not only of the IPTW estimator, but also of the G-computation,
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DR-IPTW, and targeted maximum-likelihood estimator ought to be treated as
unreliable and potentially misleading. On the basis of the more trustworthy
realistic and intention-to-treat analyses, the data suggest that high levels of
vigorous physical activity may confer reductions in mortality risk on the order
of 15-30%, although in most cases the evidence for such an effect does not quite
reach the 0.05 level of significance.
Table 7
Estimates of the relative risk of mortality (relative to A = 0) along with 95% confidence
intervals based on the bootstrap.
G-comp IPTW DR-IPTW tMLE
Static
A=1 0.90 (0.65, 1.20) 0.97 (0.68, 1.29) 0.96 (0.69, 1.28) 0.96 (0.69, 1.28)
A=2 0.91 (0.64, 1.23) 0.90 (0.60, 1.22) 0.92 (0.63, 1.27) 0.93 (0.63, 1.30)
A=3 0.88 (0.59, 1.21) 0.77 (0.44, 1.07) 0.84 (0.56, 1.14) 0.87 (0.58, 1.18)
A=4 0.59 (0.22, 1.01) 0.23 (0.06, 0.43) 0.52 (0.20, 0.92) 0.48 (0.15, 0.88)
A=5 0.86 (0.43, 1.35) 0.55 (0.21, 0.90) 0.97 (0.48, 1.50) 1.05 (0.53, 1.60)
Realistic
A=1 0.91 (0.66, 1.19) 1.00 (0.72, 1.32) 0.95 (0.70, 1.28) 0.95 (0.70, 1.28)
A=2 0.87 (0.63, 1.17) 0.97 (0.67, 1.34) 0.99 (0.66, 1.30) 1.00 (0.66, 1.32)
A=3 0.85 (0.62, 1.13) 0.81 (0.50, 1.22) 0.91 (0.59, 1.22) 0.91 (0.58, 1.23)
A=4 0.73 (0.53, 0.97) 0.58 (0.34, 1.06) 0.69 (0.40, 1.05) 0.69 (0.41, 1.05)
A=5 0.81 (0.60, 1.06) 0.66 (0.38, 1.19) 0.78 (0.47, 1.17) 0.78 (0.46, 1.20)
ITT
A=1 0.91 (0.66, 1.19) 0.99 (0.72, 1.33) 0.95 (0.70, 1.28) 0.95 (0.69, 1.28)
A=2 0.88 (0.64, 1.17) 0.98 (0.69, 1.31) 0.98 (0.67, 1.29) 0.98 (0.66, 1.30)
A=3 0.87 (0.64, 1.13) 0.85 (0.59, 1.17) 0.87 (0.61, 1.15) 0.83 (0.60, 1.14)
A=4 0.78 (0.62, 0.97) 0.85 (0.64, 1.08) 0.84 (0.63, 1.04) 0.85 (0.63, 1.10)
A=5 0.91 (0.75, 1.11) 0.96 (0.73, 1.23) 0.99 (0.73, 1.23) 1.01 (0.73, 1.30)
5. Discussion
The data analysis presented in this article illustrates the problems encountered
in attempting to estimate the causal effect of a static treatment intervention
if the ETA assumption is violated and some of the counterfactual outcomes of
interest are not even well defined. While it is fairly well known that a violation
of the ETA assumption can cause strong bias in the IPTW estimator, its effects
on other estimators of static causal effects have received little attention in the
literature. With the G-computation estimator, the DR-IPTW estimator, and
the targeted MLE all relying on extrapolation from a correctly specified model
for Q and the latter two estimators in addition requiring a mis-specified model
for the treatment mechanism that satisfies the ETA assumption, we argue that
the results offered by these three estimators must also be treated with great
caution. Since, strictly speaking, static causal effects cannot be identified from
the observed data if the ETA assumption is violated, it should in fact make
sense that the appropriate response to this problem does not lie in turning
to approaches that aim to estimate such parameters by relying on untestable
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modelling assumptions, but rather in adapting the definition of the parameter
of interest in a way that makes the parameter identifiable.
This becomes particularly obvious in cases in which static causal effects are
not even well defined. In the context of studying the causal effect of vigorous
physical activity on mortality in the elderly, for instance, it makes little sense
to talk about the counterfactual outcome distribution we would observe if all
subjects were assigned to high levels of activity since serious health problems
would prevent a considerable proportion of subjects from complying with such
an assignment. Causal effects defined on the basis of realistic individualized
treatment rules and intention-to-treat rules address this problem by explicitly
taking into account the set of treatment options that are realistically available to
each subject. Such effects are therefore well defined and identifiable even if the
full set of treatment options is not available to some subjects. The estimates of
such effects reported here suggest that high levels of vigorous physical activity
may confer reductions in mortality risk on the order of 15-30%, although in
most cases the evidence for such an effect does not quite reach the 0.05 level of
significance. Estimates of static causal effects, in contrast, suggest a statistically
significant reduction in mortality risk on the order of 50-75%, a finding that given
the estimated bias of the IPTW estimator, must be viewed as highly suspect.
A possible extension to the analysis we present here consists of data-adaptively
selecting the value for α in definition (3) of the set of realistic treatment options,
arbitrarily set by us as α = 0.05. For very small values of α, estimators of causal
effects based on realistic individualized treatment rules and intention-to-treat
rules may still be affected by a practical violation of the ETA assumption. As
the value for α is increased, on the other hand, the corresponding causal effects
become more and more different from the static causal effect that they are in
some sense intended to approximate. A more sophisticated analysis might thus
attempt to use the approach introduced by Wang et al. in order to find the
smallest value of α for which the ETA bias of the IPTW estimator is estimated
to be negligible. Future research will be required to investigate this approach
further.
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Appendix A: Targeted MLE of the causal relative risk
Let ψa = E[Yd(a,W )] and consider the parameter
θ =
E[Yd(a,W )]
E[Yd(0,W )]
=
ψa
ψ0
. (34)
Since we have already derived the efficient influence curve of ψa as
Dψa(P ) =
I(A = d(a,W ))
g(A |W )
[
Y −Q(A,W )
]
+Q(d(a,W ),W )− ψa, (35)
we can use the δ-method to find the efficient influence curve for θ. Specifically,
we have that
θ = f(ψa, ψ0) =
ψa
ψ0
(36)
and
Df = (1/ψ0,−ψa/ψ
2
0) (37)
so that the efficient influence curve for θ is given by
D(P ) = Df(Dψa(P ), Dψ0(P ))T
=
1
ψ0
{
I(A = d(a,W ))
g(A |W )
[
Y −Q(A,W )
]
+Q(d(a,W ),W )− ψa
}
−
ψa
ψ20
{
I(A = d(0,W ))
g(A |W )
[
Y −Q(A,W )
]
+Q(d(0,W ),W )− ψ0
}
=
1
ψ0
[
I(A = d(a,W ))− θI(A = d(0,W ))
]Y −Q(A,W )
g(A |W )
+
1
ψ0
[
Q(d(a,W ),W )− θQ(d(0,W ),W )
]
. (38)
The component of this influence curve corresponding to the score for P (Y |
A,W ) is given by
D(P )−E[D(P ) | A,W ] =
1
ψ0
[
I(A = d(a,W ))−θI(A = d(0,W ))
]Y −Q(A,W )
g(A |W )
.
(39)
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The covariate h(P 0n)(A,W ) needed for the univariate regression to update the
initial fit for Q is thus given by
h(P 0n)(A,W ) =
I(A = d(a,W ))− θI(A = d(0,W ))
g(P 0n)(A | W )ψ0
=
I(A = d(a,W ))− ψa/ψ0I(A = d(0,W ))
g(P 0n)(A |W )ψ0
. (40)
To obtain a feasible h(P 0n)(A,W ), we substitute
ψa,n =
1
n
n∑
i=1
Q(P 0n)(d(a,Wi),Wi) (41)
and
ψ0,n =
1
n
n∑
i=1
Q(P 0n)(d(0,Wi),Wi) (42)
for ψa and ψ0, respectively. Let ǫn denote the MLE of ǫ in Q(P
0
n)(ǫ) and let
Q1n(A,W ) =
1
1 + exp(−m0n(W )− ǫnh(P
0
n)(A,W ))
. (43)
Iterate this process k times until ǫn has become sufficiently small. Then the
targeted MLE of θ is given by
θtMLEn =
∑n
i=1Q
k
n(d(a,Wi),Wi)∑n
i=1Q
k
n(d(0,Wi),Wi)
. (44)
The covariate h(P 0n)(A,W ) for the corresponding intention-to-treat relative risk
parameter can similarly be derived as
h(P 0n)(A,W ) = I(a ∈ D)
[
1
ψ0
−
ψa
ψ20
]
+
I(a /∈ D)
[
I(A = d(a,W )) − ψa/ψ0I(A = d(0,W ))
g0n(A |W )ψ0
]
.(45)
